Accelrys brings drug discovery projects to the cloud

Accelrys ($ACCL), the San Diego-based scientific software firm, has unveiled its next-gen informatics system called the Cheminformatics Suite. The suite has new tools, including a web-based system for registering chemicals and a cloud-based system from partner Scynexis that supports the sharing of data among separate groups involved in drug discovery, according to the company. Bio-IT World covered the software release and talked to Accelrys' senior director for life sciences marketing, Rob Brown. "We're building on the joint heritage of Accelrys, MDL and Symyx--more than 25 years," Brown said. "This is the first time there's been a coherent suite to cover all capabilities that scientists need to cover daily workflows," established through a combination of in-house development with acquisitions and partnerships, he added, as quoted by Bio-IT World. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.